Stryker Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Stryker wird ein jährliches Gewinn- und Umsatzwachstum von 11.4% bzw. 7.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 11.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 22% betragen.

Wichtige Informationen

11.4%

Wachstumsrate der Gewinne

11.6%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	17.3%
Wachstumsrate der Einnahmen	7.4%
Zukünftige Eigenkapitalrendite	22.0%
Analystenabdeckung	Good
Zuletzt aktualisiert	13 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Recent updates

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Aug 10

Stryker: Wait For A Better Entry Point Post-Q2 Results

Aug 06

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

Jul 11

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Jun 30

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

Jun 19

The Returns At Stryker (NYSE:SYK) Aren't Growing

Jun 16

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Jun 05

Stryker: Margin Gains Should Drive Upside

May 31

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

May 25

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

May 14

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Apr 29

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18

Gewinn- und Umsatzwachstumsprognosen

NYSE:SYK - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	26,290	4,932	4,802	5,554	25
12/31/2025	24,406	4,436	4,381	5,080	28
12/31/2024	22,522	3,746	3,356	3,780	26
9/30/2024	21,974	3,590	3,205	3,839	N/A
6/30/2024	21,389	3,448	2,803	3,415	N/A
3/31/2024	20,963	3,361	2,858	3,470	N/A
12/31/2023	20,498	3,165	3,136	3,711	N/A
9/30/2023	19,885	2,585	2,568	3,186	N/A
6/30/2023	19,455	2,709	2,417	3,025	N/A
3/31/2023	18,952	2,627	2,267	2,866	N/A
12/31/2022	18,449	2,358	2,036	2,624	N/A
9/30/2022	17,948	2,457	2,015	2,621	N/A
6/30/2022	17,629	2,079	2,067	2,665	N/A
3/31/2022	17,430	2,015	2,453	3,014	N/A
12/31/2021	17,108	1,994	2,738	3,263	N/A
9/30/2021	16,669	1,900	3,016	3,500	N/A
6/30/2021	16,246	2,083	2,973	3,396	N/A
3/31/2021	14,716	1,408	2,712	3,138	N/A
12/31/2020	14,351	1,599	2,790	3,277	N/A
9/30/2020	14,220	1,756	2,254	2,775	N/A
6/30/2020	14,070	1,601	1,960	2,575	N/A
3/31/2020	14,956	2,164	1,798	2,469	N/A
12/31/2019	14,884	2,083	1,542	2,191	N/A
9/30/2019	14,549	3,426	1,898	2,502	N/A
6/30/2019	14,204	3,550	1,910	2,491	N/A
3/31/2019	13,876	3,522	2,053	2,626	N/A
12/31/2018	13,601	3,553	2,038	2,610	N/A
9/30/2018	13,276	1,236	1,639	2,243	N/A
6/30/2018	13,040	1,080	N/A	1,704	N/A
3/31/2018	12,730	1,019	N/A	1,705	N/A
12/31/2017	12,444	1,020	N/A	1,559	N/A
9/30/2017	12,130	1,779	N/A	1,538	N/A
6/30/2017	11,957	1,700	N/A	1,961	N/A
3/31/2017	11,785	1,689	N/A	1,804	N/A
12/31/2016	11,325	1,647	N/A	1,915	N/A
9/30/2016	10,883	1,659	N/A	1,928	N/A
6/30/2016	10,470	1,605	N/A	917	N/A
3/31/2016	10,062	1,617	N/A	781	N/A
12/31/2015	9,946	1,439	N/A	981	N/A
9/30/2015	9,849	1,177	N/A	907	N/A
6/30/2015	9,818	933	N/A	1,940	N/A
3/31/2015	9,749	669	N/A	1,953	N/A
12/31/2014	9,675	515	N/A	1,782	N/A
9/30/2014	9,525	641	N/A	1,775	N/A
6/30/2014	9,287	687	N/A	1,873	N/A
3/31/2014	9,136	772	N/A	1,859	N/A
12/31/2013	9,021	1,006	N/A	1,886	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SYKDas prognostizierte Gewinnwachstum (11.4% pro Jahr) liegt über der Sparquote (2.6%).

Ertrag vs. Markt: SYKDie Erträge des Unternehmens (11.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.5% pro Jahr).

Hohe Wachstumserträge: SYKDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: SYKDie Einnahmen des Unternehmens (7.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: SYKDie Einnahmen des Unternehmens (7.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SYKDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (22%)

Stryker Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Recent updates

Independent Director recently sold US$84m worth of stock

Independent Director notifies of intention to sell stock

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Treace Medical Concepts, Inc. Files Lawsuit Against Stryker Corporation and Its Subsidiary Wright Medical Technology, Inc

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker Corporation (NYSE:SYK) completed the acquisition of Vertos Medical Inc.

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker Corporation (NYSE:SYK) acquired NICO Corporation.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) completed the acquisition of Care.ai inc.

Stryker Corporation (NYSE:SYK) acquired The Osteotomy Truss System (OTS) and Ankle Truss System of 4WEB Inc.

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Second quarter dividend of US$0.80 announced

Independent Director notifies of intention to sell stock

Stryker Announces Launch of Pangea Plating System

Stryker: Wait For A Better Entry Point Post-Q2 Results

VP & CFO recently sold US$6.7m worth of stock

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Second quarter 2024 earnings: EPS misses analyst expectations

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

VP & CFO exercised options and sold US$3.7m worth of stock

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

Stryker: Margin Gains Should Drive Upside

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

VP & CFO recently sold US$3.3m worth of stock

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

First quarter dividend of US$0.80 announced

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

VP & CFO exercised options and sold US$8.3m worth of stock

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Insufficient new directors